Transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care
blog

5 Tips to Help Workers’ Comp Payers Optimize IT Resources

The insurance sector is experiencing an IT talent shortage. How can workers’ comp payers optimize the IT resources they already have?
Read More
rxinformer

Things Change: The Growing Diversity of Pharmacy Cost Drivers

Smaller, more niche drug trends across different populations and geographies
Read More
INDUSTRY SURVEY

2023 Industry Insights Survey Report

We surveyed 500+ workers’ comp professionals on the biggest industry disruptors and priorities
Read More

Featured Videos

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

Lot of Methocarbamol Recalled Due to White Particles

Patients taking this muscle relaxant may be impacted by a lot from Eugia US/AuroMedics Pharma.

Apr 2024

Cardiovascular Drug Approvals

As firefighters see more presumptions for heart disease, keeping track of heart medications could grow in importance.

Apr 2024

2024 Workers’ Comp Industry Insights Survey Report

Visit Healthe at RISKWORLD® 2024 at Booth #1833 for your copy or download a copy now.

Apr 2024

Rhode Island Proposes Worker Climate Protection

If enacted, Senate Bill 2900 would require worker protections from extreme heat and cold.

Apr 2024

More States Consider Cancer Presumptions for Firefighters

Different types of cancers are being added to pre-existing presumptions.

Apr 2024

Visit Healthesystems at RISKWORLD 2024

Pick up a copy of the new Summer 2024 edition of RxInformer magazine, and learn how Healthe is transforming healthcare.

Apr 2024

New Autoimmune Biosimilar Approved and Alzheimer’s Drug Goes Generic

Simlandi injection was approved for arthritic conditions, while Namzaric receives its first generic approval.

Mar 2024

Novel Migraine Agents: What is Their Place in Injured Worker Therapy?

As the market grows, it becomes necessary to understand efficacy, costs, and alternatives.

Mar 2024

CWCI Reports on Cumulative Trauma in Litigated Claims

Tenure more than age and other factors had a higher association with cumulative trauma claims.

Mar 2024

AI Utilization Review Bills Appear Across the Country

California, Georgia, New York, Oklahoma, and Pennsylvania could start a national trend.

Mar 2024

Three More States Introduce Psychedelics Bills, While FDA Sets MDMA Decision Date

Connecticut, Missouri, and New Hampshire join 10 other states considering psychedelics bills.

Mar 2024

Medical Issues Panel at IAIABC Forum & The Fear of Reinjury in Workers’ Comp

Amanda Waltemath, Director of Clinical Services joins a panel discussion on April 10th, and Tate Rice, Director of Product Management speaks to Risk & Insurance.

Mar 2024

Novel Migraine Agents: What Is Their Place in Injured Worker Therapy?

Novel migraine agents are continuing to enter the market, providing alternative forms of pain relief for migraine sufferers. What are the efficacy and cost considerations for injured workers?

Mar 2024

FDA Evaluates Report of Suicidal Thoughts with GLP-1 Inhibitors

While no clear link is established to these obesity and diabetes drugs, the FDA will continue to monitor data.

Feb 2024

2024 Workers’ Comp Industry Insights Survey Report

This sixth annual survey report highlights the top challenges and priorities of 500 industry professionals.

Feb 2024

U.S. Department of Labor Issues Final Rule on Worker Classification

The rule clarifies differences between employees and contractors, establishing who is entitled to benefits – including workers’ comp.

Feb 2024

Ten Psychedelic Bills Introduced Across State Legislatures

States so far include Alaska, Arizona, California, Hawaii, Indiana, Illinois, Massachusetts, Maryland, New Jersey, and Wisconsin.

Feb 2024

FDA Approves First Test to Help Identify Risks of Developing Opioid Use Disorder

The AvertD test is intended to be used prior to first exposure to oral opioids in patients considered for a 4-30 day prescription for acute pain.

Feb 2024

Department of Health and Human Services Reveals Cannabis Rescheduling Findings

With many federal agencies in alignment, the ultimate decision rests with the DEA.

Feb 2024

FDA Issues Respective Warnings for Compounded and Counterfeit Semaglutide

The growing demand for this drug has led individuals to search for semaglutide from alternative sources.

Jan 2024

The Mind-Body Connection: Exploring the Relationship Between Injury and Mental Health

Injuries accompanied by mental health disorders can increase claim costs and delay recovery.

Jan 2024

Growing Shifts in Child Labor Laws

Many states passed or proposed changes in 2023, with two states so far working on bills for 2024.

Jan 2024

White House Pardons Simple Possession Charges for Marijuana

A recent proclamation applies to simple federal possession charges on or before December 22, 2023.

Jan 2024

PTSD Presumptions Could See More Action in 2024

As legislative sessions open, several states have continued to introduce PTSD bills.

Jan 2024

Emerging/Current Medical and Drug Trends

Healthe’s VP of Clinical Services, Silvia Sacalis, will co-present at the 20th Annual Workers’ Compensation Insurance ExecuSummit.

Jan 2024

This Year’s Top Insights in Workers’ Compensation Medical Management

As we enter 2024, let’s look at the top insights for workers’ comp managed care programs in 2023.

Jan 2024

FDA Warns of Rare Drug Interactions with Antiseizure Drugs

Hypersensitivity reactions may start as a rash but can quickly result in injury to internal organs.

Dec 2023

Beyond Opioids: Drugs of Concern in Workers’ Compensation

As opioid utilization decreases, other pharmacy trends bear watching.

Dec 2023

Comorbidities and Recovery After Physical Therapy for Low Back Pain

A new WCRI report utilizes data from 68,850 workers from 2017-2021.

Dec 2023

Bureau of Labor Statistics Reports on Workplace Injuries and Illnesses

Employers reported 2.8 million nonfatal workplace injuries and illnesses in 2022, an increase of 7.5% from 2021.

Dec 2023

1 2 3 4 5 16 17 18 19 20
lockenvelopephone-handsetmagnifiermenuarrow-rightcross-circle